MS4A2 抗体 (AA 1-59)
MS4A2
适用: 人
WB, ELISA
宿主: 小鼠
Monoclonal
3B1
unconjugated
-
-
抗原
See all MS4A2 抗体
-
MS4A2
(Membrane-Spanning 4-Domains, Subfamily A, Member 2 (Fc Fragment of IgE, High Affinity I, Receptor For, beta Polypeptide) (MS4A2))
-
抗原表位
-
AA 1-59
-
适用
-
人
-
宿主
-
小鼠
-
克隆类型
-
单克隆
-
标记
-
This MS4A2 antibody is un-conjugated
-
应用范围
-
Western Blotting (WB), ELISA
-
交叉反应
-
人
-
交叉反应 (详细)
-
Calculated cross reactivity: Hu
-
产品特性
-
MS4A2 (High Affinity Immunoglobulin epsilon Receptor Subunit beta, FcERI, Fc epsilon Receptor I beta-chain, IgE Fc Receptor Subunit beta, Membrane-spanning 4-domains Subfamily A Member 2, APY, FCER1B, IGER)
-
纯化方法
-
Purified by Protein A affinity chromatography.
-
免疫原
-
Partial recombinant corresponding to aa1-59 from human MS4A2 (NP_000130) with GST tag. MW of the GST tag alone is 26kD.
-
克隆位点
-
3B1
-
亚型
-
IgG2a kappa
-
Top Product
-
Discover our top product MS4A2 Primary Antibody
-
anti-Membrane-Spanning 4-Domains, Subfamily A, Member 2 (Fc Fragment of IgE, High Affinity I, Receptor For, beta Polypeptide) (MS4A2) (AA 51-150) antibody
MS4A2
适用: 人, 小鼠
WB, ELISA, IF (cc), IF (p), IHC (fro), IHC (p), ICC
宿主: 兔
Polyclonal
unconjugated
-
-
应用备注
-
Optimal working conditions should be determined by the investigator.
-
限制
-
仅限研究用
-
-
状态
-
Liquid
-
缓冲液
-
Supplied as a liquid in PBS, pH 7.2.
-
储存条件
-
-20 °C
-
储存方法
-
-20°C
-
-
抗原
-
MS4A2
(Membrane-Spanning 4-Domains, Subfamily A, Member 2 (Fc Fragment of IgE, High Affinity I, Receptor For, beta Polypeptide) (MS4A2))
-
别名
-
MS4A2 (MS4A2 产品)
-
别名
-
APY antibody, ATOPY antibody, FCER1B antibody, FCERI antibody, IGEL antibody, IGER antibody, IGHER antibody, MS4A1 antibody, FcRB antibody, Fce1b antibody, Fcer1b antibody, Fcrbeta antibody, Ms4a1 antibody, fcERI antibody, FCIGA antibody, membrane spanning 4-domains A2 antibody, membrane-spanning 4-domains, subfamily A, member 2 antibody, MS4A2 antibody, Ms4a2 antibody
-
NCBI登录号
-
NM_000139, NP_000130
-
途径
-
Fc-epsilon Receptor Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-